Active Pharmaceutical Ingredients Inspection Backlog Imports Product Development Regulatory Affairs Chemical Safety Towa Pharmaceutical Eli Lilly Corporate Investments in Healthcare Drug Shortages Supply Disruptions Production Facilities Damage Sterile Injectable Medicines Supply Chain Disruptions Plant Recovery Tariffs on Drugs Ibrexafungerp Contamination Medicine Production Zero Gravity Manufacturing